Kumamoto University
Recent studies add new data to HIV/AIDS vaccines research
Published in Law and Health Weekly, December 17th, 2005
Study 1: Scientists have identified an HLA-A*3101-restricted cytotoxic T-lymphocyte (CTL) response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
"Virus-specific cytotoxic T-lymphocyte (CTL) responses are critical in the control of human immunodeficiency virus type 1 (HIV-1) infections. As several HIV-1 CTL epitopes restricted to many HLA types are already known, we aimed at identifying the CTL epitopes restricted by HLA-A*3101 in an effort to expand the epitope repertoire available for the development of potential T cell-mediated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Cooley Godward, LLP
Law firm expands Washington, DC, office and life sciences patent practice - Healthcare Coverage
Cancer treatment systems get 37% boost in reimbursement - Healthcare Coverage
Pharmacy benefits management firm to provide Medicare Part D program - Huazhong University of Science & Technology in Wuhan
Poor quality 3-day old embryos can develop into blastocysts - Information Technology
Regal Medical Group licenses software to automate managed care functions - Lorus Therapeutics Inc.
Cancer-focused biopharma company announces corporate changes - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
